Balyasny Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-44,346
| Closed | -$213K | – | 2192 |
|
|
2022
Q4 | $213K | Sell |
44,346
-706,727
| -94% | -$3.4M | ﹤0.01% | 1675 |
|
|
2022
Q3 | $4.27M | Sell |
751,073
-1,048,434
| -58% | -$5.96M | 0.01% | 822 |
|
|
2022
Q2 | $12.8M | Buy |
1,799,507
+1,788,546
| +16,317% | +$12.7M | 0.04% | 470 |
|
|
2022
Q1 | $79K | Sell |
10,961
-243,657
| -96% | -$1.76M | ﹤0.01% | 1821 |
|
|
2021
Q4 | $2.28M | Buy |
+254,618
| New | +$2.28M | 0.01% | 980 |
|
|
2021
Q3 | – | Sell |
-399,227
| Closed | -$8.58M | – | 1663 |
|
|
2021
Q2 | $8.58M | Buy |
+399,227
| New | +$8.58M | 0.04% | 496 |
|